Yu, Lu
Wang, Huifang
Gale, Robert Peter
Qin, Yazhen
Lai, Yueyun
Shi, Hongxia
Dou, Xuelin
Huang, Xiaojun
Jiang, Qian http://orcid.org/0000-0001-7131-0522
Funding for this research was provided by:
National Natural Science Foundation of China (81970140, 81770161)
Article History
Received: 25 March 2021
Accepted: 29 March 2021
First Online: 9 April 2021
Declarations
:
: RPG is a consultant to BeiGene Ltd., Fusion Pharma LLC, LaJolla NanoMedical Inc., Mingsight Parmaceuticals Inc. and CStone Pharmaceuticals; advisor to Antegene Biotech LLC, Medical Director, FFF Enterprises Inc.; partner, AZAC Inc.; Board of Directors, Russian Foundation for Cancer Research Support; and Scientific Advisory Board: StemRad Ltd.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethics standards.